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Liver fibrosis is an adaptive response to various injuries and may eventually progress to cirrhosis. Although there are several non-invasive
methods available to monitor the progression of liver fibrogenesis, they cannot reliably detect fibrosis in its early stages, when the process can be
stopped or reversed by removing or eliminating the underlying etiological agent that cause the hepatic injury. In this study, early fibrosis
alterations were characterized biochemically, morphologically, and spectroscopically in a rat bile duct ligation (BDL) model. Progressive
elevations in serum alanine transaminase (ALT), aspartate transaminase (AST), and bilirubin levels in the BDL rats were found indicating the
dynamic deterioration of hepatocellular function. Immunofluorescence microscopy using monoclonal anti-collagen III antibody further revealed
abnormal intertwined networks of collagen fibres surrounding the portal areas and extending into the lobules towards the central veins in all BDL
samples starting from week one. Synchrotron infrared microspectroscopy of liver sections was exploited to generate false color spectral maps
based upon a unique and strong collagen absorption at 1340 cm−1, revealing a collagen distribution that correlated very well with corresponding
images provided by immunofluorescence imaging. We therefore suggest that infrared microspectroscopy may provide an additional and sensitive
means for the early detection of liver fibrosis.
© 2006 Elsevier B.V. All rights reserved.Keywords: Liver fibrosis; Cirrhosis; Infrared; Mapping; Collagen1. Introduction
Liver fibrosis and cirrhosis are common sequelae of chronic
liver injuries, emerging through wound-healing processes in the
liver. Progressive formation of a fibrillar extracellular matrix
(ECM) in the liver is the consequence of repeated liver injuries in
response to a variety of insults, including chronic viral infection
(commonly hepatitis B and C), toxins (e.g., alcohol), and both
metabolic and autoimmune disorders [1]. Liver fibrosis results
from a dynamic process in which fibrillar ECM formation is
associated with ECM degradation and remodelling. This is a
balanced process that may either progress to an advanced stage⁎ Corresponding author. Tel.: +1 204 984 6476; fax: +1 204 984 5472.
E-mail address: Kan-Zhi.Liu@nrc.ca (K.-Z. Liu).
0005-2736/$ - see front matter © 2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2006.05.006defined as ‘cirrhosis’ or be reversed to restore normal hepatic
structure and function [2]. Cirrhosis is characterized by the
formation of regenerative nodules of liver parenchyma that are
separated by and encapsulated in fibrotic septa and is associated
with major angio-architectural changes. It is generally considered
that liver fibrosis is reversible while cirrhosis is irreversible unless
an effective treatment for the underlying insult is available.
The need for rapid, safe and reliable methods to detect and
monitor the liver fibrogenic progression has become an urgent
clinical reality due to increased knowledge regarding the me-
chanisms responsible for hepatic fibrogenesis and hence the intro-
duction of potentially more effective therapeutic strategies [3]. The
concept of a ‘fibrosis progression rate’ has implications for risk
stratification, prognosis and for the evaluation of therapy [4].
Although there has been considerable effort to identify serum mar-
kers as non-invasivemeasures of hepatic fibrosis, e.g., alterations in
Table 1
Serum markers for hepatic functions in sham and BDL-treated group
0 week 2 weeks 4 weeks
ALT Sham 78.0±3.2 63.0±3.5 61.0±1.0
BDL-treated 68.6±5.1 176.0±15.1* 165.5±18.6*
AST Sham 109.6±2.9 98.3±14.9 145.5±44.5
BDL-treated 112.3±24.1 645.5±126.9* 763.7±97.1*
BIL Sham 0.5±0.2 0.9±0.3 1.1±0.4
BDL-treated 0.7±0.3 8.2±1.5* 8.2±1.2*
ALT and AST are in units/liter and bilirubin in mg/dl. The data were obtained
from twelve rats for each group and are depicted as Mean±SE.
* indicate significant differences (Pb0.05).
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hydroxylysine levels, the accuracy and predictive value of these
measures are insufficient to provide the basis for clinical decision-
making [5,6]. From the clinical standpoint, liver biopsy is still
considered the ‘gold standard’ to confirm the clinical diagnosis, to
assess the severity of necro-inflammation and fibrosis, to evaluate
possible concomitant disease processes, and to guide therapeutic
intervention. However, needle liver biopsy is associated with
potential morbidity and mortality and has a high rate of sampling
error in patients with diffuse parenchymal liver diseases [7]. For
instance, needle liver biopsy sampling error may occur despite an
adequate sample size and a satisfactory sampling of portal tracts,
when evaluating the severity of inflammation [8], the degree of
fibrosis [9], and presence of cirrhosis [7]. The present approach, if
successful, might permit routine, accurate, non-subjective diagnos-
tic assessment of very small-bore needle biopsies, minimizing
morbidity and at the same time providing clear guidance in the
evaluation of treatment options.
While biopsy samples are often stained with either hema-
toxylin and eosin (H&E) or specific connective tissue stains
such as Masson's trichrome or reticulin silver impregnation
[10], visualization of fibrosis is not easy and underestimation of
the fibrillar ECM network is common [3]. Therefore, most pa-
thologists routinely resort to more specific approaches such as
picrosirius red staining [11] or immunofluorescence [12] that
provide excellent definition of the distribution of fibrillar
collagens (i.e., collagen type I and type III) [13]. These methods
clearly reveal the connective tissue structure of liver tissue, in-
cluding aspects of both perisinusoidal and pericellular fibrosis.
Infrared microspectroscopy offers the means to characterize the
nature and distribution of tissue components by virtue of dif-
ferences among the mid-IR spectra of those components. For
example, IR microspectroscopy has been used to demonstrate
differences between diseased and normal colon [14], cervical [15],
and brain [16] tissues, and changes in composition with apoptosis
and necrosis [17]. Of particular relevance here, IR microspectro-
scopy has been utilized previously to reveal the spatial distribution
of collagen (and other components) within both cardiac and oral
cancer tissues [18,19]. Collagens exhibit a series of unique IR
absorption bands between 1000 and 1350 cm−1, and these have
been exploited in previous studies characterizing collagen tissue
distribution [18–23]. For instance, an absorption at 1204 cm−1 was
used as a marker band to characterize collagen distribution in heart
tissue and oral cancers [18,19], while a band at 1338 cm−1 was
shown to be directly related to the quantity of collagen in cartilageand exploited for a study of prostatic hyperplasia [21,22]. Liver
tissue has been characterised by infrared microspectroscopy in two
previous studies [23,24].
The spatial resolution of conventional infrared microspec-
troscopy is limited by diminishing signal-to-noise with small
apertures. Therefore, fine tissue architectural features cannot be
resolved with regular infrared microspectroscopy. Fortunately,
this problem can be alleviated by employing synchrotron
infrared radiation as a source, since it is 1000 times brighter than
a standard black-body source. As a result, spectra with good
signal-to-noise may be acquired with apertures at or near the
diffraction limit [25,26]. By utilizing a synchrotron IR source, it
is possible to resolve tissue architectural features at a spatial
resolution near the diffraction limit (∼10 μm at 1000 cm−1), and
to reveal structures that would not otherwise be resolved by
conventional IR microspectroscopy.
Therefore, in the current study, we made use of synchrotron
infrared microspectroscopy (at the National Synchrotron Light
Source) to examine the distribution of liver fibrosis within a rat
model, and compared the resulting maps to images produced
from the same tissue section by immunofluorescence staining
(monoclonal anti-collagen III antibody).
2. Material and methods
2.1. Animal model
A total of twenty-four adult male Sprague–Dawley rats were obtained from the
Animal Facility of the University of Manitoba. All rats were maintained under
12-h light/dark cycles with food and water ad libitum. All animals received humane
care in compliance with criteria set by the Canadian Council on Animal Care. These
rats were divided into two groups, sham-operated and bile duct ligation (BDL),
respectively. Since theBDLmodel represents themajor features of liver fibrosiswith
significant modification of ECM and has been used most frequently for the
investigation of liver fibrosis, we implemented this model according to a procedure
described previously [27–30]. Briefly, the animal was subjected to mild anesthesia
and the common bile duct was exposed by median laparotomy and occluded by
double ligature with a nonresorbable suture (7-0 silk). The first tie was made below
the junction of the hepatic ducts and the second was made above the entrance of the
pancreatic duct. The common bile duct was then resected between the two ligatures,
and the abdominal incision was closed. Liver specimens were then collected weekly
(4 animals weekly; 24 animals total), up to 6 weeks following BDL by excision of
the entire liver. These specimens were frozen in liquid nitrogen immediately
following removal, and stored at −70 °C for further analysis.
2.2. Serum and liver biochemistry
Blood samples were obtained from the saphenous vein of rats at 0, 2, and
4 weeks intervals after sham or BDL procedures. The serum concentrations of
alanine transaminase (ALT) and aspartate transaminase (AST) were determined
using a Roche-Hitachi 917 Clinical Chemistry Analyzer with Roche application
kit while bilirubin levels were measured using a bilirubin assay kit from Sigma
(Sigma-Aldrich Inc, St. Louis, USA).
2.3. Liver histology
Frozen liver samples (approx. 0.5 cm3) were randomly taken from the right,
median and left lobes of each rat liver and sectioned consecutively at 5 μm using a
cryostat at −18 °C. These sections were mounted on slides and air dried for at least
20 min followed by fixation in 10% Formalin for 30 s. Then these sections were
stained with routine Haematoxylin and Eosin according to regular staining
procedure such as hydration, staining, dehydration and clearing. The stained slides
were finally covered with a cover-slip using a mounting medium Entellen.
Fig. 1. Representative liver tissues stainedwith hematoxylin and eosin (×100magnification). A: SHAMgroup (4weeks); B: BDLgroup (1week); C: BDLgroup (2weeks);
D: BDL group (4 weeks).
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Frozen, unfixed liver samples were embedded in optimal temperature cutting
(OCT) compound, sectioned consecutively at 10 μm in a cryostat at −18 °C and
mounted on 25 mm barium fluoride windows. These windows permitted both
immunofluorescence staining and infrared microspectroscopic imaging (regular
glass slides are opaque to mid-IR radiation). The tissue sections were then fixed in
pre-cooled 100% acetone (− 20 °C) for 10 min, washed twice with PBS, then
incubated with Alexa Fluor 488 (Molecular Probes, Eugene, USA) conjugated
monoclonal anti-collagen III antibody (Sigma-Aldrich Inc, St. Louis, USA) in a
humid chamber at 37 °C for 60 min in the dark. This monoclonal anti-collagen III
antibody is produced in mouse and the species reactivity are human and rat. The
concentration of the antibodywas 1:625. Thewindowswere thenwashed three times
with PBS andmountedwith coverslips using fluorescentmountingmedium (DAKO
Diagnostics Canada, Inc,Mississauga, Canada). Negative controls were treated with
omission of the monoclonal anti-collagen III antibody on adjacent sections cut from
the same tissue sample. These sections were examined using an inverted Nikon
Eclipse TS100 microscope equipped with Nikon Plan Fluor objectives (Nikon,
Tokyo, Japan), a Fluor filter set (Omega Optical, Brattleboro, USA) and a 300 W
Xenon light source (Intracellular Imaging Inc, Cincinnati, USA). Microfluoro-
graphic images were captured as monochrome digital signals by a Cohu 2600 series
CCD camera (Cohu, Inc., Electronics Division, San Diego, USA) coupled to the
microscope. The fluorescence intensities were calibrated with the InSpeck
Microscope Image Intensity Calibration Kits (Molecular Probes, Eugene, USA) to
keep the experimental conditions constant for each experiment. The fluorescence
images in Fig. 2 were generated from this fluorescence imaging system.
2.5. IR microspectroscopy
Infrared spectra of liver tissue sections were collected using a FTIR microscope
attached to a Nicolet Magna 860 spectrometer that receives its source light from
Beamline U2B at the National Synchrotron Light Source, Brookhaven National
Laboratory, Upton, NY [31]. Specifically, liver sections stained with Alexa Fluor488 conjugated monoclonal anti-collagen III antibody were mounted on IR
transparent BaF2 windows and placed in position for mid-IR microspectroscopic
measurements. Avideo camera mounted to the microscope captured visible images
before data collection. Prior to spectral data collection, fluorescence images were
obtained, using an Olympus BX-FLA fluorescence accessory mounted to the IR
microscope [32] with a specific filter set (excitation: 460–500 nm; dichroic: 505 nm;
emission: 510–540 nm; Chroma Technology Corp., Brattleboro, VT). These
permitted precise registration of features within the IR microspectroscopy images
with their fluorescence counterparts.
An adjustable aperture was placed before the objective to limit the IR illu-
mination area to a 10 by 10μmpixel, calibrated using a visible light image at its focal
point. For each pixel, a spectrum was acquired using 64 coadditions and Happ-
Genzel apodization at 4 cm−1 resolution. Prior to data collection, a background
spectrum through air (no sample) was collected as a reference so data could be
converted to absorbance. The spectral data were acquired using Atlus software
(ThermoNicolet InstrumentsCorporation). FTIR spectra for each pixelwithin the IR
map were first smoothed using the Savitsky–Golay algorithm, followed by the
application of a second derivative operation within the microspectroscopy imaging
software (CytoSpec; www.cytospec.com) employed to generate IR images.
2.6. Statistical analysis
ANOVAwas used to analyze differences in serummarker levels for the sham
vs. BDL groups. Differences with P values below 0.05 were deemed to be
significant.3. Results
In the current study, early fibrosis was investigated in a rat
bile duct ligation model using morphological and spectroscopic
methods. Analysis of plasma enzymes carried out in parallel
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(ALT), aspartate transaminase (AST) and bilirubin levels which
usually suggest the dynamic deterioration of hepatocellular
function, and are indicative of cholestatic liver disease [33–35].
A 2.5-fold increase in ALT and a 6.5-fold increase in ASTwere
observed after the first 2 weeks of bile duct ligation, and the
activities of these two enzymes remained elevated throughout
the experimental period (Table 1). Similar results were also
observed for bilirubin.
Routine H&E staining was employed to characterize
representative liver sections from sham and BDL groups at
various timepoints following BDL occlusion, as displayed in
Fig. 1. The liver tissue from sham group (Fig. 1A) showed a
portal track (portal triad) in the middle with its bile ductule and
hepatic arterial and portal venous branches. The hepatocytes
had normal histological appearance, i.e., they were polyhedral
with eosinophilic cytoplasm and a usually central nucleus. Bet-
ween the cords of hepatocytes are endothelially lined sinusoids.
Neither inflammatory cell infiltration nor portal or periportal
fibrosis was found. However, for the BDL group, mild bile duct
proliferation was evident in the portal tract after the first week
and progressively exacerbated thereafter, associated with some
mild inflammatory cell infiltrate around the ducts and portal
vessels (Fig. 1B–D). Specifically, after 2 weeks of BDL, the
typical ductular reaction associated with progressive deposition
of extracellular matrix surrounding the newly formed bile ducts
became obvious (Fig. 1C). At the fourth week of BDL, theFig. 2. Representative liver tissues immunofluorescence-stained with Alexa Fluor 488 c
group (4 weeks); B: BDL group (1 week); C: BDL group (2 weeks); D: BDL group (4alteration of liver structure was even more evident, with brid-
ging fibrosis encircling most of the newly formed bile ducts
(Fig. 1D).
To further confirm the early stage of fibrosis in this BDL
model, and to create a molecular image of collagen deposition
and distribution for comparison with the IR maps, we carried
out immunofluorescence staining of the liver section with Alexa
Fluor 488 conjugated monoclonal anti-collagen III antibody
(Fig. 2). As expected, in the sham tissue, only blood vessels and
bile ducts (both of which are rich in collagen) are visible while
the hepatocytes, lymphocytes, Kupffer, and sinusoidal en-
dothelial cells are invisible in the dark field (Fig. 2A). However,
in the BDL model, newly formed bile ducts were readily de-
tected by fluorescence staining; some deposition of fibrous
tissue was observed as early as the first week following BDL
(Fig. 2B). After 2 weeks of BDL, newly formed bile ducts
progressively invaded the other parts of the lobule and were
surrounded by fibrous tissue (Fig. 2C). By the fourth week post-
BDL, an intense fluorescent network was evident, revealing
extensive interweaved and threaded fibrils within the liver tissue
ECM (Fig. 2D).
Prior to processing and interpretation of the IR microspectro-
scopic liver tissue spectra, we compared the spectrum of calf type
III collagen (Sigma-Aldrich Inc, St. Louis, USA) to that of normal
liver tissues to characterize the basic spectroscopic differences
between normal hepatocytes and collagenous tissue (Fig. 3). The
IR spectrum of liver tissue showed the absorptions typical of tissueonjugated monoclonal anti-collagen III antibody (×100 magnification). A: SHAM
weeks).
Fig. 3. Infrared spectra for normal liver tissue and pure type III collagen.
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two prominent absorptions at 1652 cm−1 and 1542 cm−1 arise from
C_O stretching (amide I) and N–H bending (amide II) vibrationsFig. 4. Section from 1-week post-BDL liver tissue stained with immunofluorescence m
from pixels coincident with representative fibrotic (B) and normal (C) liver.of the protein peptide groups [36]. The bands marked as sPO2
− and
asPO2
−, located at 1087 and 1240 cm−1, are the symmetric and
asymmetric PO2
− stretching vibrations of the DNA phosphodiesteronoclonal anti-collagen III antibody (A). Comparison of infrared spectra obtained
Fig. 5. Collagen distribution images. Immunofluorescence-stained (1-weekBDL) liver tissue section image (A) is compared to the corresponding digital image (B) and two-
dimensional contour map (C) derived from the 1338 cm−1 collagen absorption within the infrared microspectroscopic map for the same tissue section.
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at 1240 cm−1), and lipids contributed a band centered at 1740 cm−1
that originates from the ester C_O group.
The major spectral features distinguishing collagen and liver
tissue are the collagen absorptions between 1000 and 1350 cm−1
arising from vibrations of the collagen sidechains, predominantly
from the proline groups. A number of infrared absorptions which
are highly characteristic of collagen have been identified pre-
viously, and used as IRmarkers of collagen deposition in the heart
and other tissues [18–20,37]. Here, we have chosen to use the
marker band at 1338 cm−1, since other collagen absorptions in
this region overlap heavily with DNA bands in the liver tissue
(Fig. 3). To confirm that this dominant collagen band can indeed
be used for the detection of liver fibrosis, we extracted absorption
spectra representative of a high fluorescence area (collagen-rich)
and a low fluorescence area as shown in Fig. 4. As expected, the
band at 1338 cm−1 is significantly stronger within the fibrotic,
collagen-enriched area as compared to normal liver, as demon-
strated in Fig. 4B and C. The collagen band at 1338 cm−1 was
therefore adopted as the basis to map collagen deposition for
detection and characterization of liver fibrosis.
To investigate the overall collagen deposition within the liver
sections from BDL rats, immunofluorescence staining with Alexa
Fluor 488 conjugated monoclonal anti-collagen III antibody was
used as a gold standard to reveal the subtle fibrosis in a liver section
after 1 week of BDL (Fig. 5A). A grid of IR spectra was also
obtained from the same area by raster-scanning synchrotron IR
microspectroscopy, to provide the basis to generate IR maps. Im-
aging software (CytoSpec) was then used to import these spectral
data and produce false color images generated from the intensity of
the 1338 cm−1 collagen band. As shown in Fig. 5B and C, an IR
false color image and two-dimensional contour map accurately
recover the distribution of collagen deposition in the liver section,
as revealed by the collagen-specific immunofluorescence photo-
micrograph (Fig. 5A). Moreover, while the IR false color map
mimics the collagen distribution pattern as revealed qualitatively by
the immunofluorescence photomicrograph, the two dimensional
contour map goes further, permitting quantification of the collagen
deposition in the same section (Fig. 5B and C).4. Discussion
Common bile duct ligation and scission in rats, as used in this
study, represents a classical experimentalmodel for the analysis of
the events from the initial injury of the bile ducts through the
organization of a fibrotic reaction [25,38]. The combination of
raised intra-biliary pressure, release of inflammatory mediators,
anoxia, and the cytotoxic effect of bile acids induce inflammatory
processes leading to hepatic fibrosis and finally to secondary
biliary cirrhosis [39]. The major advantages of this model are the
significant infiltration of the connective tissues in the portal zone
and enhanced proliferation of bile duct epithelial cells and hepa-
tocytes; therefore, it is often used to understand ECM expression
and its regulation during the cholestasis, and hepatocyte pro-
liferating activity in the fibrosis process [39].
The BDL model was successfully established in the current
study, as reflected by the morphologic changes within the liver
sections and by the associated serum biochemical alterations
reflecting deteriorated liver function (Fig. 1 and Table 1), in
agreement with previous studies [38–41]. Immunofluorescence
imaging of these BDL liver sections further revealed the structural
changes characteristic of this model, including disordered liver
architecture with bile duct proliferation and fibrous deposition in
the intracellular matrix (Fig. 2). Moreover, these pathological
changes were observed to be time dependent; by the fourth week
of BDL, severe collagen deposition was observed in the intra-
cellular matrix, including significant infiltration of connective
tissue in the portal zone and progressive accumulation of newly
formed bile ducts. Therefore, this model – in conjunction with
immunofluorescence imaging – can be reliably employed to
evaluate the feasibility and accuracy of IR mapping for the early
detection of liver fibrosis, as executed in the current protocol.
It is well documented that the visualization of fibrosis in the
liver specimen is not always easy with routine H&E staining or
with Masson's trichrome, which can underestimate the extension
of fibrosis [3]. The adaptation of more specific methods on a
routine basis is therefore considered crucial. These alternative
methods include picrosirius red staining [11] which provides an
excellent characterization of the distribution of fibrillar collagens
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reasonable analysis of the connective tissue structure of liver
tissue, including features of pericellular and perisinusoidal fibrosis
[13]. Other methods such as immunohistochemistry for proteins
typical of fibrillar ECM (e.g., pro-collagen type I, III, and VI,
tenascin, etc.) have also proposed, although these remain at the
experimental stage [42]. Immunofluorescence staining was the
best choice for the current protocol since it can reveal specific
collagen types (e.g., type III) while not interfering with IR
measurements. Therefore, simultaneous determination of collagen
deposition in the tissuewas possible by both IRmicrospectroscopy
and immunofluorescence staining within the same area of interest
from same slide with excellent registration (Fig. 5).
It is well known that the ECM of liver is composed of several
molecular forms of collagen (predominantly types I, III and IV)
and noncollagenous components such as undulin, elastin, fibro-
nectin, and laminin [43]. With liver fibrosis, the total content of
collagens and noncollageneous components increases, accompa-
nied by a shift of ECM from a low-density basement membrane-
like matrix (e.g., type IV) to an interstitial type matrix containing
fibril-forming collagens (type I, III) [44]. It has also been suggested
that collagen type III and fibronectin accumulate in the early liver
injury whereas collagen I, IV, undulin, elastin and laminin pre-
dominate in the chronic or late stage [44,45]. Thus, the employ-
ment of type III collagen antibody is appropriate for the current
study, focussed on detection and characterization of the early
stages of liver fibrosis (Fig. 2).
Because the fibrillar network is so diffuse and filamentous in
nature, IR microspectroscopy at lower spatial resolution would be
incapable of resolving the structures so clearly revealed by the
fluorescence image of Fig. 5A. The dominant advantage of syn-
chrotron microspectroscopy is illustrated well by the images of
Fig. 5B and C, which do faithfully reproduce the general features
revealed by immunofluorescence staining. It is also important to
point out, however, that the representative IR image does not
perfectlymatch the corresponding fluorescence stained image.The
discrepancies may originate from any of several sources. Most
likely, we believe, is the specificity of the collagen stain. Although
the most dominant collagen in the early stage of liver fibrosis is
type III, other collagens such as collagen type I and fibronectin are
also implicated in the alteration of liver ECM. While the
immunofluorescence image would not reflect these collagens, IR
microspectroscopywould. A second source of discrepancymay be
the fact that the spatial resolution of IRmicrospectroscopy is lower
than that of the fluorescence imaging technique. The resolution of
synchrotron IR microspectroscopy (10 μm in the mid-infrared
region) [46] does not match the resolution of the immunofluores-
cence image, which is on the order of 0.5 μm [47]. Therefore, it is
not surprising to see that the images generated by immunofluo-
rescence and IR imaging techniques are not perfect matches.
In summary, IRmicrospectroscopy can detect liver fibrosis with
its own unique “false color imaging” approach to reveal the subtle
and early fibrosis within the ECM. IRmicrospectroscopy possesses
numerous potential advantages over traditional approaches to
regular pathology. For instance, fixation and staining of tissues are
not required before histological viewing. Secondly, since the IR
spectrum simultaneously samples numerousmolecular species, it iscapable (for example) of detecting various collagen types asso-
ciated with fibrosis, e.g., collagen I, III, IVand fibronectin, without
resorting to separate antibodies as required by immunofluorescence
or other histopathologic methods. Furthermore, additional bio-
chemical information (e.g., DNA, RNA, glycogen, lipids content)
is available simultaneously from same spectroscopic dataset, as
exploited in previous spectroscopic liver studies [23,24]; this fea-
ture can provide additional information regarding the severity of
fibrosis. Further studieswill focus on the use of IR digital staining to
quantify liver fibrosis from very small samples (e.g., needle biop-
sies) both for the routine confirmation of clinical diagnosis and to
guide therapeutic intervention.
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